PSMA vs AXUMIN PET/CT in prostate cancer

Jeremie Calais, MD, from the University of California, Los Angeles, CA, talks about 18F-fluciclovine (AXUMIN) vs 68Ga-PSMA-11 (PSMA) PET/CT molecular imaging in prostate cancer. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.


Xem thêm các bài viết về Sức Khỏe:

Leave a Comment